A study comparing two approved doses of rituximab in ANCA vasculitis
Not Applicable
- Conditions
- Health Condition 1: I778- Other specified disorders of arteries and arterioles
- Registration Number
- CTRI/2023/07/055677
- Lead Sponsor
- Professor Aman Sharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age >18 years,Active vasculitis defined as BVAS = 1.
Exclusion Criteria
1.Any active infection at the time of recruitment.
2.Active tuberculosis of any site in last six months.
3. Hepatitis B, C or human immunodeficiency virus I/II infection.
4.Abnormal liver function tests at the time of recruitment.
5.Prior use of Rituximab for remission induction in the last six months.
6.Active malignancy or history of malignancy in the last 5 years.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method